FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153715608> ?p ?o ?g. }

• W2153715608 endingPage "109" @default.
• W2153715608 startingPage "100" @default.
• W2153715608 abstract "Insulin sensitivity and insulin clearance are compromised in end-stage renal disease but it has not been fully established whether they are altered in earlier stages of diabetic nephropathy.We studied three groups of patients with type 1 diabetes; 10 with no sign of nephropathy, 11 with albuminuria (> 20 microg min-1) but normal glomerular filtration rate (GFR) and eight with a small reduction in GFR, (43-73 mL min-1 1.73 m-2). The groups were matched for age (range 36-61 years), body mass index (BMI), diabetes duration and glycaemic control. The euglycaemic hyperinsulinaemic clamp technique was utilized to study insulin sensitivity (M-value) and metabolic clearance rate for insulin. Needle biopsies from abdominal subcutaneous fat tissue were obtained to study insulin binding, insulin degradation, insulin-stimulated glucose uptake and anti-lipolysis in adipocytes in vitro.Patients with reduced GFR were more insulin-resistant (M-value 5.7 +/- 0.7 mg kg LBM-1 min-1) than those without nephropathy (9.6 +/- 0.7, P = 0.001) and those with only albuminuria (8.9 +/- 1.2, P = 0.044). In all subjects taken together there was a strong association between insulin sensitivity and GFR (r = 0.46, P = 0.012). Patients with reduced GFR displayed no significant difference in insulin clearance (12.2 +/- 1.6 mL kg-1 min-1) compared to controls (13.8 +/- 1.3) but a slightly lower insulin clearance than patients with only albuminuria (16.6 +/- 1.0, P = 0.027). There were no significant differences between patient groups in the adipocyte studies in vitro, i.e. with respect to insulin binding, insulin degradation and the effects of insulin on glucose uptake and lipolysis. This is compatible with humoral factors causing whole-body insulin resistance and in the group with reduced GFR, we found that serum parathyroid hormone, interleukin-6 and tumour necrosis factor-alpha levels were elevated whereas the morning cortisol was decreased.In type 1 diabetes, the appearance of albuminuria does not seem to alter insulin sensitivity and clearance. A marked insulin resistance but no consistent impairment in insulin clearance seems to accompany progression to a stage with a slight reduction in GFR. These alterations are not accompanied by general defects in insulin target cells. Instead, alterations in the regulation of insulin-antagonistic hormones and cytokines could potentially contribute to the development of insulin resistance in diabetic nephropathy." @default.
• W2153715608 created "2016-06-24" @default.
• W2153715608 creator A5026866614 @default.
• W2153715608 creator A5044288681 @default.
• W2153715608 creator A5044939013 @default.
• W2153715608 date "2002-02-01" @default.
• W2153715608 modified "2023-10-18" @default.
• W2153715608 title "A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy" @default.
• W2153715608 cites W1579174150 @default.
• W2153715608 cites W1838497045 @default.
• W2153715608 cites W1969759774 @default.
• W2153715608 cites W1974033843 @default.
• W2153715608 cites W1975654557 @default.
• W2153715608 cites W1976347558 @default.
• W2153715608 cites W1979363410 @default.
• W2153715608 cites W1980111447 @default.
• W2153715608 cites W1981694993 @default.
• W2153715608 cites W1982245891 @default.
• W2153715608 cites W1983523234 @default.
• W2153715608 cites W1992116875 @default.
• W2153715608 cites W1995101619 @default.
• W2153715608 cites W2017023426 @default.
• W2153715608 cites W2036266922 @default.
• W2153715608 cites W2041391173 @default.
• W2153715608 cites W2065569245 @default.
• W2153715608 cites W2068854446 @default.
• W2153715608 cites W2084820112 @default.
• W2153715608 cites W2088009836 @default.
• W2153715608 cites W2094017043 @default.
• W2153715608 cites W2099215676 @default.
• W2153715608 cites W2101354639 @default.
• W2153715608 cites W2102619594 @default.
• W2153715608 cites W2103844937 @default.
• W2153715608 cites W2105912552 @default.
• W2153715608 cites W2109963685 @default.
• W2153715608 cites W2134293572 @default.
• W2153715608 cites W2136566419 @default.
• W2153715608 cites W2139623768 @default.
• W2153715608 cites W2142834180 @default.
• W2153715608 cites W2145027776 @default.
• W2153715608 cites W2146059428 @default.
• W2153715608 cites W2151831906 @default.
• W2153715608 cites W2160329850 @default.
• W2153715608 cites W2186184337 @default.
• W2153715608 cites W2326347426 @default.
• W2153715608 cites W2339343999 @default.
• W2153715608 cites W4234050533 @default.
• W2153715608 cites W4234645077 @default.
• W2153715608 cites W4242273886 @default.
• W2153715608 cites W4247933975 @default.
• W2153715608 doi "https://doi.org/10.1046/j.1365-2362.2002.00949.x" @default.
• W2153715608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11895456" @default.
• W2153715608 hasPublicationYear "2002" @default.
• W2153715608 type Work @default.
• W2153715608 sameAs 2153715608 @default.
• W2153715608 citedByCount "33" @default.
• W2153715608 countsByYear W21537156082012 @default.
• W2153715608 countsByYear W21537156082013 @default.
• W2153715608 countsByYear W21537156082016 @default.
• W2153715608 countsByYear W21537156082017 @default.
• W2153715608 countsByYear W21537156082020 @default.
• W2153715608 countsByYear W21537156082021 @default.
• W2153715608 countsByYear W21537156082023 @default.
• W2153715608 crossrefType "journal-article" @default.
• W2153715608 hasAuthorship W2153715608A5026866614 @default.
• W2153715608 hasAuthorship W2153715608A5044288681 @default.
• W2153715608 hasAuthorship W2153715608A5044939013 @default.
• W2153715608 hasConcept C126322002 @default.
• W2153715608 hasConcept C134018914 @default.
• W2153715608 hasConcept C159641895 @default.
• W2153715608 hasConcept C2776174234 @default.
• W2153715608 hasConcept C2777180221 @default.
• W2153715608 hasConcept C2777391703 @default.
• W2153715608 hasConcept C2778808658 @default.
• W2153715608 hasConcept C2779306644 @default.
• W2153715608 hasConcept C2779922275 @default.
• W2153715608 hasConcept C2780352109 @default.
• W2153715608 hasConcept C2781184683 @default.
• W2153715608 hasConcept C2781203188 @default.
• W2153715608 hasConcept C555293320 @default.
• W2153715608 hasConcept C71924100 @default.
• W2153715608 hasConceptScore W2153715608C126322002 @default.
• W2153715608 hasConceptScore W2153715608C134018914 @default.
• W2153715608 hasConceptScore W2153715608C159641895 @default.
• W2153715608 hasConceptScore W2153715608C2776174234 @default.
• W2153715608 hasConceptScore W2153715608C2777180221 @default.
• W2153715608 hasConceptScore W2153715608C2777391703 @default.
• W2153715608 hasConceptScore W2153715608C2778808658 @default.
• W2153715608 hasConceptScore W2153715608C2779306644 @default.
• W2153715608 hasConceptScore W2153715608C2779922275 @default.
• W2153715608 hasConceptScore W2153715608C2780352109 @default.
• W2153715608 hasConceptScore W2153715608C2781184683 @default.
• W2153715608 hasConceptScore W2153715608C2781203188 @default.
• W2153715608 hasConceptScore W2153715608C555293320 @default.
• W2153715608 hasConceptScore W2153715608C71924100 @default.
• W2153715608 hasIssue "2" @default.
• W2153715608 hasLocation W21537156081 @default.
• W2153715608 hasLocation W21537156082 @default.

• next